Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
School of Mathematical and Physical Sciences, Macquarie University, Sydney, Australia.
Trials. 2023 Mar 16;24(1):197. doi: 10.1186/s13063-023-07119-0.
Exercise for the prevention of low back pain recurrences is recommended, but under-researched. The effectiveness and cost-effectiveness of a walking program for preventing low back pain recurrence remains unknown. This a priori statistical analysis plan describes the methods of analysis for the WalkBack trial.
WalkBack is a prospectively registered, pragmatic, randomised controlled trial. The aim is to investigate the effectiveness and cost-effectiveness of a 6-month progressive and individualised walking and education program (intervention) for the prevention of low back pain recurrences, compared to a no-treatment control group. The primary outcome is days to the first recurrence of an episode of activity-limiting low back pain. Key secondary outcomes include days to any recurrence of low back pain, days to a care-seeking recurrence of low back pain, disability level, health-related quality of life, costs associated with low back pain and adverse events. All participants will be followed for a minimum of 12 months. Analysis will follow the intention-to-treat principle. Cox regression is planned to assess the effects for the outcomes of time to activity-limiting, minimal and care-seeking recurrence. Hazard ratios and median survival times with 95% confidence intervals will be calculated. The effect of the intervention on continuous outcomes will be estimated with repeated-measure linear mixed models. An economic evaluation will be performed from the societal perspective for recurrence prevented (yes/no) and quality-adjusted life years. The proportion of adverse events between groups will be compared using Fisher's exact test.
The WalkBack trial will provide evidence on the effectiveness and cost-effectiveness of a walking intervention to prevent low back pain recurrences. This statistical analysis plan provides transparency on the analysis of the trial.
WalkBack - Effectiveness and cost-effectiveness of a progressive individualised walking and education program for the prevention of a recurrence of low back pain. ACTRN12619001134112 . Date Registered: 14/08/2019.
建议进行预防腰痛复发的运动,但对此研究较少。目前尚不清楚步行方案预防腰痛复发的有效性和成本效益。本预先设定的统计分析计划描述了 WalkBack 试验的分析方法。
WalkBack 是一项前瞻性注册的、实用的、随机对照试验。目的是调查 6 个月渐进式个体化步行和教育方案(干预)预防腰痛复发的有效性和成本效益,与无治疗对照组进行比较。主要结局是首次出现活动受限性腰痛发作的复发天数。关键次要结局包括腰痛复发天数、寻求治疗的腰痛复发天数、残疾程度、健康相关生活质量、腰痛相关成本和不良事件。所有参与者将至少随访 12 个月。分析将遵循意向治疗原则。计划采用 Cox 回归评估对活动受限、最小和寻求治疗复发的结局的影响。将计算风险比和中位数生存时间及其 95%置信区间。将采用重复测量线性混合模型估计干预对连续结局的影响。将从社会角度对预防复发(是/否)和校正生命质量调整年进行经济评估。将使用 Fisher 精确检验比较组间不良事件的比例。
WalkBack 试验将提供关于预防腰痛复发的步行干预措施的有效性和成本效益的证据。本统计分析计划提供了对试验分析的透明度。
WalkBack-渐进式个体化步行和教育方案预防腰痛复发的有效性和成本效益。ACTRN12619001134112。注册日期:2019 年 8 月 14 日。